Time-dose factor (TDF) analysis of dose rate effects in permanent implant dosimetry.
Orton CG, Webber BM.
Int J Radiat Oncol Biol Phys. 1977 Jan-Feb;2(1-2):55-60. doi: 10.1016/0360-3016(77)90008-6.
Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix.
Yudelev M, Kuten A, Tatcher M, Rubinov R, Karmeli R, Cohen Y, Robinson E.
Gynecol Oncol. 1986 Mar;23(3):310-5. doi: 10.1016/0090-8258(86)90131-9.
Time, dose and fractionation factor as an indicator of fibrosis of the abdominopelvic subcutaneous tissue.
Lederman MV, Faria SL, Malzyner A, Vizeu DM.
Int J Radiat Oncol Biol Phys. 1982 Aug;8(8):1447-8. doi: 10.1016/0360-3016(82)90598-3.
Volume correction factor in time dose relationships in brachytherapy.
Supe SJ, Sasane JB, Gupta MK.
Strahlenther Onkol. 1987 May;163(5):309-13.
On the problem of time, dose and fractionation (TDF) in the linear-quadratic model.
Ulmer W.
Strahlentherapie. 1985 Mar;161(3):177-85.
[Practical use of the TDF factor in radiotherapy of basalioma and squamous cell carcinoma].
Bahmer FA.
Hautarzt. 1992 Oct;43(10):625-8.
Recent developments in time-dose modelling.
Orton CG.
Australas Phys Eng Sci Med. 1991 Jun;14(2):57-64.
Dependence of tolerance dose on irradiated volume in radiotherapy, and determination of volume corrected time, dose and fractionation factors.
Gupta MK, Ajayi DO.
Clin Radiol. 1982 Nov;33(6):615-20. doi: 10.1016/s0009-9260(82)80382-6.
Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy.
Maruyama Y, Wierzbicki J.
Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1561-8. doi: 10.1016/0360-3016(90)90373-r.
The time dose fractionation (TDF) relationship in the radiotherapy of carcinoma of the cervix.
Swamy K, Supe S, Kumar MU, Viswanathan N, Anantha N.
Strahlenther Onkol. 1991 Oct;167(10):603-7.
